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A  nasal  NK/T  cell  lymphoma  is  a  very  aggressive  form  of  lymphoma.  Patterns  of  relapse  after  treatment  have  not 
been  systematically  evaluated,  and  mediastinal  nodal  relapse  at  a  primary  site  has  never  been  documented.  We 
describe  here  a  40-year  old  man  who  presented  with  a  nasal  obstruction  caused  by  a  protruding  mass  that  was 
identified  as  a  nasal  NK/T  cell  lymphoma.  The  initial  work-up,  including  chest  and  abdominopelvic  computed 
tomography  (CT)  and  positron  emission  tomography  (PET),  showed  no  regional  or  distant  metastasis.  A  CT  scan 
performed  following  three  cycles  of  chemotherapy  with  cyclophosphamide,  doxorubicin,  vincristine,  and  prednisolone 
(CHOP)  showed  that  the  mass  had  nearly  disappeared.  Radiation  therapy  undertaken  following  chemotherapy  was 
given  to  the  primary  site.  However,  PET  performed  following  radiotherapy  revealed  a  single  mediastinal 
lymphadenopathy,  with  no  evidence  of  residual  tumor  in  the  nasal  cavity.  A  biopsy  using  video-assisted  thoracoscopy 
(VATS)  showed  the  presence  of  a  recurrent  NK/T  cell  lymphoma  with  an  immunophenotype  identical  to  that  of  the 
primary  nasal  lymphoma.  An  additional  three  cycles  of  CHOP  chemotherapy  were  administered,  and  the  patient 
remains  alive,  with  no  evidence  of  disease  30  months  after  the  initial  relapse.  These  findings  indicate  that  early 
detection  with  PET  and  prompt  surgical  excision  with  the  use  of  VATS  can  lead  to  successful  treatment  of  a  relapsed 
nasal  NK/T  cell  lymphoma. 
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INTRODUCTION
Natural  killer  (NK)/T-cell  lymphoma  is  the  most  common 
subtype  of  primary  nasal  lymphoma
1).  Nasal  NK/T  cell 
lymphoma  is  a  very  aggressive  form  of  lymphoma,  with  over 
50%  of  the  tumors  showing  involvement  of  the  adjacent  alveolar 
bones,  hard  palate,  orbits,  nasopharynx  and  an  association  with 
an  extensive  soft-tissue  mass
2).  Relapse  patterns  of  nasal  NK/T 
cell  lymphoma  after  treatment  have  not  been  systematically 
evaluated,  and  mediastinal  nodal  relapse  at  a  controlled  primary 
site  has  not  been  previously  reported.  Here  we  report  a  case  of 
mediastinal  single  nodal  relapse  of  a  NK/T  cell  lymphoma, 
detected  by  positron  emission  tomography  (PET)  and  confirmed 
pathologically,  which  was  removed  completely  with  surgery 
using  video-assisted  thoracoscopy  (VATS).
CASE REPORT
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to  Asan  Medical  Center,  Seoul,  Korea,  in  December  2003  with 
symptoms  of  nasal  obstruction  and  fever.  A  radiological 
examination  of  the  paranasal  sinus  disclosed  a  soft  tissue  mass 
in  the  left  middle  meatus  and  associated  obstructive  sinusitis  in 
the  left  maxillary  sinus  (Figure  1).  A  rhinoscopic  examination 
revealed  an  irregular,  and  partly  ulcerated  protruding  mass 
occupying  the  nasal  cavity.  A  punch  biopsy  showed  the 
presence  of  extensively  necrotic  tissue  with  a  few  viable  foci  of 
sheets  of  atypical  medium-  to  large-sized  lymphocytes  with 
irregularly  shaped  nuclei.  Individual  necrosis  and  apoptosis  were 
frequent.  The  tumor  cells  were  positive  by  immunostaining  for 
CD3,  CD  56,  cytotoxic  granule  marker  TIA-1,  and  UCHL-1 
(CD45RO),  but  negative  for  CD20,  CD79a,  CD4,  and  CD8.  In 
situ  hybridization  showed  the  presence  of  Epstein-Barr  virus  in 
the  majority  of  the  tumor  cell  nuclei.  The  patient  was  diagnosed 
with  an  extranodal  CD  56+  nasal  NK/T  cell  lymphoma.
To  evaluate  the  disease  status,  computed  tomography  (CT), 
bone  marrow  aspiration  and  biopsy,  and  PET  were  performed. 
CT  showed  no  abnormal  findings  in  other  areas.  Fluorine-18 
fluorodeoxyglucose  (FDG)  PET  showed  a  focal  hypermetabolic 
lesion  with  a  4.8  maximal  standardized  uptake  value  (SUV)  in 
the  left  nasal  cavity,  but  no  abnormally  hypermetabolic  lesions  in 
the  chest  or  abdomen  (Figure  2,  Figure  3A).  All  of  these  findings 
were  consistent  with  a  stage  IEB  nasal  NK/T  cell  lymphoma. 
Hematological  levels  were  hemoglobin  12.8  g/dL,  hematocrit 
36.9%,  platelet  count  172×10
3/mm
3,  and  white  blood  cell  count 
4,200/mm
3  (66%  neutrophils,  29%  lymphocytes,  5%  monocytes, 
and  0.5%  eosinophils).  A  bone  marrow  biopsy  showed  no 
malignant  cell  infiltration.  All  blood  chemistry  findings  were 
normal,  except  for  a  slightly  elevated  lactate  dehydrogenase 
level  of  379  IU/l  (normal  range  120-250  IU/l).  A  cytological 
examination  of  the  cerebrospinal  fluid  showed  no  abnormalities. 
The  patient  was  treated  with  three  cycles  of  chemotherapy, 
consisting  of  cyclophosphamide,  doxorubicin,  vincristine,  and 
prednisolone  (CHOP),  followed  by  28  fractions  of  local  radiation 
therapy  to  the  primary  site,  with  a  total  dose  of  5,040  cGy. 
In  April  2004,  about  one  month  after  completion  of  the 
radiation  therapy,  FDG  PET-CT  revealed  a  newly  developed 
focal  hypermetabolic  lesion  with  a  maximal  SUV  of  3.6  in  the 
aorto-pulmonic  nodal  station.  There  were  no  abnormal  findings 
at  other  sites,  except  for  post-radiation  sinusitis  and  thyroiditis 
(Figure  3B).  A  biopsy  using  VATS  was  performed,  and  the 
lymph  node  was  removed  completely.  Microscopically,  the  node 
showed  numerous  histiocytes  and  epithelioid  granulomas  and 
scattered  medium-sized  CD56-positive  lymphocytes  in  the 
paracortex;  the  nuclei  of  these  cells  were  positive  for 
Epstein-Barr  virus.  The  tissue  specimen  of  the  mediastinal 
lymph  node  showed  histology  similar  to  that  of  the  nasal  mass 
(Figure  4A-D).
The  patient  was  treated  with  an  additional  three  cycles  of 
CHOP  chemotherapy.  A  follow-up  chest  CT  and  PET  showed 
no  evidence  of  residual  tumor.  Thirty-five  months  after  the  initial 
diagnosis  and  thirty  months  after  the  initial  relapse,  the  patient 
is  still  alive,  without  any  evidence  of  further  relapse.
DISCUSSION
An  extranodal  NK/T  cell  lymphoma  is  characterized  by 
extensive  mucosal  ulceration  and  angiocentric  or  angiodestruc-
tive  lymphomatous  infiltration.  These  tumors  have  an  immun-
ophenotype  of  NK/T  cell  neoplasms,  including  expression  of 
cytoplasmic  CD  3  epsilon  and  CD56,  and  many  are  positive  for 
EBV
3, 4).  These  NK  cell  lymphomas  show  a  geographic 
predilection,  in  that  they  are  more  common  in  Asian  regions 
such  as  Hong  Kong,  Japan,  and  Korea,  and  in  Latin  American 
countries  including  Mexico,  Peru,  and  Guatemala
5-7).
“Nasal”  NK/T  cell  lymphomas  are  classified  as  lesions 
confined  within  the  nasal  cavity  and  nasopharynx,  whereas 
“nasal-type”  NK/T  cell  lymphomas  are  lesions  involving  sites 
outside  the  nasal  cavity/nasopharynx,  such  as  the  oral  cavity, 
palate,  larynx,  tonsil,  skin,  soft  tissues,  and  the  visceral 
organs
4, 8, 9).  The  prognosis  for  patients  with  primary 
non-Hodgkin's  lymphoma  of  the  nasal  cavity  is  poor,  and  the 
rates  of  distant  metastasis  and  local  relapse  are  high.  The 
5-year  overall  survival  and  disease-free  survival  rates  for  102 
patients  with  stage  IE  nasal  NK/T  cell  lymphoma  have  been 
recently  reported  to  be  71.7%  and  60.9%,  respectively
10). 
Outcomes  of  262  extranodal  NK/T  cell  lymphomas  were  recently 
used  to  develop  a  prognostic  model  of  these  tumors,  with  new 
prognostic  factors  including  B  symptoms,  stage,  lactate 
dehydrogenase  (LDH)  level,  and  regional  lymph  node  status
11). 
According  to  this  model,  our  patient,  who  had  B  symptoms  and 
an  elevated  LDH  level,  is  in  group  3  (two  risk  factors).
Because  of  the  low  incidence  and  geographic  occurrence  of 
these  tumors,  a  systematic  evaluation  of  the  treatment  for  nasal 
NK/T  cell  lymphomas  has  not  been  fully  performed.  Therefore, 
the  optimal  therapy  for  nasal  NK/T-cell  lymphoma  has  not  yet 
been  established.  Although  a  prospective  randomized  trial  about 
optimal  treatment  has  not  been  performed,  several  retrospective 
studies  have  shown  radiotherapy  to  be  superior  to 
chemotherapy  alone  for  stage  I/II  disease
12, 13).  Some  studies 
report  that  the  addition  of  chemotherapy  to  radiotherapy  does 
not  appear  to  confer  any  survival  benefit  in  early  stage 
patients
13, 14).
  Consequently  radiotherapy,  either  as  the  initial 
treatment  or  as  part  of  the  chemotherapy  regimen,  is  presently 
the  mainstay  of  a  treatment  program  for  early  stage  NK/T  cell 
lymphoma.  The  patient  in  this  case  was  treated  with  three 
cycles  of  chemotherapy,  followed  by  in  field  radiation  therapy  as 
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Figure  2.  FDG  PET  of  the  nasal  cavity  at  the  initial  diagnosis. 
There was a focal hypermetabolic lesion in the left nasal cavity at 
the  initial  diagnosis. 
Figure 1. Computed tomography of the paranasal sinus showing a 
soft  tissue  density  mass  in  the  left  middle  meatus  and  associated 
obstructive  sinusitis  in  the  left  maxillary  sinus.
   
Figure 3. FDG PET of  the mediastium at the initial diagnosis  (A) and  at relapse (B). (A) There was no abnormal hypermetabolic lesion 
in  the  chest  and  abdomen  at  the  initial  diagnosis.  (B)  There  was  increased  metabolic  activity  at  the  mediastinal  lymph  node  of  the  AP 
window  (maximal  SUV=3.6).  Diffuse  increased  uptake  was  observed  in  both  thyroid  glands,  indicative  of  thyroiditis.
Secondary  lymph  node  involvement  is  rarely  encountered 
until  late  in  the  course  of  disease
15).  In  the  patient  described 
here,  we  diagnosed  mediastinal  relapse  promptly  using  PET,  a 
highly  sensitive  diagnostic  tool  for  various  cancers  that  can 
detect  increased  glucolytic  activity  of  neoplasms
16).  PET  is 
usually  performed  to  diagnose  and  stage  tumors  and  to  monitor 
response  to  therapy
17).  Although  CT  is  frequently  performed  for 
patients  with  lymphoma,  it  is  less  sensitive  for  small  tumor  foci. 
Following  treatment  of  a  lymphoma,  CT  can  reveal  residual 
masses  or  enlarged  lymph  nodes,  which  may  or  may  not 
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Figure  4.  Initial  biopsy  of  the  nasal  mass  showing  an  extranodal  NK/T-cell  lymphoma  (A,  B)  and  biopsy  of  the  mediastinal  lymph  node 
showing tumor recurrence (C, D). (A) Viable tumor cells show perivascular distribution in an extensively necrotic background containing an 
abundance  of  apoptotic  bodies.  Note  the  irregular,  hyperchromatic  nuclei  and  variable  amount  of  clear  to  eosinophilic  cytoplasm  of  the 
tumor cells (×4000, H and E staining). (B) In situ hybridization for Epstein-Barr virus showing signals in the tumor cell nuclei. (C) A few 
scattered  atypical  medium  to  large  lymphocytes  were  admixed  with  small,  mature,  reactive  lymphocytes  and  numerous  histiocytes  in the 
paracortex  of  the  effaced  node  with  hyperplastic  high  endothelial  venules  (×400,  H  and  E  staining).  (D)  In  situ  hybridization  for 
Epstein-Barr virus showing positive signals in the tumor cell nuclei. The pathological and immunohistochemical features of the mediastinal 
lymph  node  were  identical  with  those  of  the  nasal  mass.
contain  a  viable  tumor
18, 19).  Lymphoma  evaluation  using  CT  is 
primarily  dependent  on  the  size  and  morphologic  criteria  used  to 
differentiate  a  malignant  from  a  reactive  lymph  node.  However, 
even  a  single  small  lymph  node  could  be  a  lymphoma  site.  The 
patient  described  here  had  a  single  mediastinal  lymph  node  of 
1  cm  in  size.  Evaluation  by  CT  alone,  without  PET,  would  have 
made  the  diagnosis  difficult  and  would  have  affected  the 
decision  in  deciding  whether  the  patient  should  have  been 
further  evaluated  by  the  use  of  VATS.
Various  techniques  can  be  used  to  perform  diagnostic 
mediastinal  biopsies,  the  most  widely  used  being  the  use  of 
percutaneous  fine-needle  aspiration,  cervical  mediastinoscopy, 
parasternal  mediastinotomy,  open  biopsy  through  a  thoraco-
tomy,  and  more  recently  VATS
20).  VATS  is  currently  indicated 
not  only  for  diagnostic  procedures,  but  also  for  its  versatility, 
permitting  other  surgical  treatments  at  the  same  time. 
Mediastinoscopy  is  still  the  most  widely  used  procedure  for 
mediastinal  lymph  node  biopsy,  but  access  to  the 
aorticopulmonary  window  may  be  difficult  and  is  limited  by  the 
aorta  and  left  main  bronchus.  However,  VATS  makes  it  possible 
to  reach  all  lymph  node  stations,  including  the  posterior 
subcarinal,  paraesophageal,  and  prevertebral  stations
20).
AB
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The  potentially  aggressive  behavior  of  relapsed  NK/T-cell 
lymphomas  makes  early  and  correct  pathological  diagnosis  and 
prompt  treatment  important.  The  patient  described  here 
developed  a  single  mediastinal  nodal  relapse  one  month  after 
initial  treatment  of  the  nasal  NK/T  cell  lymphoma,  and  was 
diagnosed  and  treated  using  PET  and  VATS.  This  patient  is  still 
alive  35  months  after  the  initial  diagnosis  and  30  months  after 
the  initial  relapse  without  any  evidence  of  further  relapse.
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